Kathleen A. Cronin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kathleen A. Cronin has a total of 132 co-authors. Here are the top co-authors by number of shared publications:
- Nadia Howlader
Surveillance Research Program Division of Cancer Control and Population Sciences National Cancer Institute Bethesda Maryland USA
20 shared publications - Angela B. Mariotto
National Cancer Institute 1 Division of Cancer Control and Population Sciences Bethesda, Maryland
17 shared publications - Manami Bhattacharya
Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute , Rockville, MD, USA
17 shared publications - Amy E. Wood
Essex Management, National Cancer Institute, Bethesda, Maryland
16 shared publications - Elad Sharon
Dana Farber Cancer Institute, Boston, Massachusetts, United States
16 shared publications - Lori A. Ehrlich
Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
16 shared publications
Latest Publications
- 1 October 2026
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 118 (10) , 1987
Stat Bite: Breast cancer subtype incidence rates in women under 50 from 2019 to 2023
- 1 October 2026
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 118 (10) , 1987
Stat Bite: Breast cancer subtype incidence rates in women under 50 from 2019 to 2023
- Open Access
Annual Report to the Nation on the Status of Cancer, featuring 21st century progress against lung cancer
Background: This annual report represents a collaborative effort by leading cancer surveillance organizations to present reliable, comprehensive US statistics on cancer incidence and mortality. Methods: Cancer incidence data were obtained from population‐based cancer registries funded by the Centers for Disease Control and Prevention and/or the National Cancer Institute and compiled by the North American Association of Central Cancer Registries. Cancer death data were obtained from the National Center for Health Statistics’ National Vital Statistics System. Age‐standardized rates (per 100,000) and average annual changes in rates calculated with joinpoint regression are reported by cancer type, sex, race and ethnicity, and age. Lung cancer risk factors and outcomes during 2000–2025 were assessed. Results: Overall cancer incidence rates were 504.6 among males and 443.0 among females during 2018–2019/2021–2022. Excluding 2020, cancer incidence rates were stable among males (2013–2022) and increased 0.4% per year among females (2011–2022). Lung cancer incidence decreased 3.5% among males and 1.9% among females per year during 2018–2022. During 2019–2023, overall cancer death rates were 171.5 among males and 126.3 among females, decreasing 1.6% per year among males and 1.1% among females. During this period, lung cancer death rates decreased 4.7% per year among males and 3.0% among females. Since the early 2000s, smoking fell by one half, early diagnosis of lung cancer increased by two thirds, and 5‐year relative survival for lung cancer doubled. Conclusions: Cancer incidence was stable among males but increased slowly among females. Cancer mortality continued to decline, largely because of sustained progress against lung cancer.
Open AccessAnnual Report to the Nation on the Status of Cancer, featuring 21st century progress against lung cancer
Background: This annual report represents a collaborative effort by leading cancer surveillance organizations to present reliable, comprehensive US statistics on cancer incidence and mortality. Methods: Cancer incidence data were obtained from population‐based cancer registries funded by the Centers for Disease Control and Prevention and/or the National Cancer Institute and compiled by the North American Association of Central Cancer Registries. Cancer death data were obtained from the National Center for Health Statistics’ National Vital Statistics System. Age‐standardized rates (per 100,000) and average annual changes in rates calculated with joinpoint regression are reported by cancer type, sex, race and ethnicity, and age. Lung cancer risk factors and outcomes during 2000–2025 were assessed. Results: Overall cancer incidence rates were 504.6 among males and 443.0 among females during 2018–2019/2021–2022. Excluding 2020, cancer incidence rates were stable among males (2013–2022) and increased 0.4% per year among females (2011–2022). Lung cancer incidence decreased 3.5% among males and 1.9% among females per year during 2018–2022. During 2019–2023, overall cancer death rates were 171.5 among males and 126.3 among females, decreasing 1.6% per year among males and 1.1% among females. During this period, lung cancer death rates decreased 4.7% per year among males and 3.0% among females. Since the early 2000s, smoking fell by one half, early diagnosis of lung cancer increased by two thirds, and 5‐year relative survival for lung cancer doubled. Conclusions: Cancer incidence was stable among males but increased slowly among females. Cancer mortality continued to decline, largely because of sustained progress against lung cancer.
- 1 August 2026
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 118 (8) , 1560-1561
Stat Bite: Recent trends in cancer mortality from 2020 to 2024
- 1 August 2026
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 118 (8) , 1560-1561
Stat Bite: Recent trends in cancer mortality from 2020 to 2024
- 15 July 2026
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
Recent trends in early-onset cancer incidence rates
The increasing incidence of early-onset cancers is a growing concern. Using newly released Surveillance Epidemiology and End Results data incorporating 2023 incidence rates, we evaluated emerging trends by comparing 5-year average annual percent changes (AAPC) in incidence rates for 2018-2022 and 2019-2023 across the 22 most common cancer types in individuals under 50 years of age. The AAPC changed significantly for liver and intrahepatic bile duct cancer from 2.6% (non-significant) in 2018-2022 to 3.7% (increasing) in 2019-2023. For non-Hodgkin lymphoma and lung and bronchus cancer, AAPCs changed from −0.5% to 1.1% and from −2.0% to 0.3%, respectively (decreasing to non-significant). A continuous increase in incidence rates was observed for cancers including but not limited to colorectal cancer (excluding appendix) and ovarian cancer. These findings underscore the need for robust cancer registry data to support surveillance research and inform prevention and control efforts in younger populations.
- 15 July 2026
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
Recent trends in early-onset cancer incidence rates
The increasing incidence of early-onset cancers is a growing concern. Using newly released Surveillance Epidemiology and End Results data incorporating 2023 incidence rates, we evaluated emerging trends by comparing 5-year average annual percent changes (AAPC) in incidence rates for 2018-2022 and 2019-2023 across the 22 most common cancer types in individuals under 50 years of age. The AAPC changed significantly for liver and intrahepatic bile duct cancer from 2.6% (non-significant) in 2018-2022 to 3.7% (increasing) in 2019-2023. For non-Hodgkin lymphoma and lung and bronchus cancer, AAPCs changed from −0.5% to 1.1% and from −2.0% to 0.3%, respectively (decreasing to non-significant). A continuous increase in incidence rates was observed for cancers including but not limited to colorectal cancer (excluding appendix) and ovarian cancer. These findings underscore the need for robust cancer registry data to support surveillance research and inform prevention and control efforts in younger populations.
- 1 April 2026
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 118 (4) , 766-767
Stat Bite: A reversal of esophageal cancer mortality between non-Hispanic Black and White individuals in the United States
- 1 April 2026
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 118 (4) , 766-767
Stat Bite: A reversal of esophageal cancer mortality between non-Hispanic Black and White individuals in the United States
- 1 March 2026
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 118 (3) , 556
Stat Bite: Recent trends in ovarian cancer among Non-Hispanic Black and Non-Hispanic White women
- 1 March 2026
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 118 (3) , 556
Stat Bite: Recent trends in ovarian cancer among Non-Hispanic Black and Non-Hispanic White women
- Open Access
- 14 January 2026
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 35 (2) , 193-197
The Paul Fearn Award for Excellence in Data Sharing in Cancer Control and Population Sciences
The secondary use of data can accelerate innovation and drive discoveries, tool development, and reproducibility. Though data sharing can be challenging, policies and incentives can help facilitate and reward these efforts. To maximize the value of data produced through NIH awards, the NIH recently set forth comprehensive, modern data sharing requirements for all funded research with the 2023 NIH Data Management and Sharing Policy. In light of this new comprehensive policy, the NCI’s Division of Cancer Control and Population Sciences (DCCPS) saw an opportunity to reward exemplary data sharers and add an incentive for future data sharing through the development of an award. In 2024, DCCPS established the “Paul Fearn Award for Excellence in Data Sharing” to promote recognition and celebrate data sharing within the field of population sciences. In its inaugural year, the award was given to researchers from four different projects, each exemplary in the sharing of DCCPS-funded work. Each awardee went above and beyond data sharing requirements to make data reusable for others. Their distinct data sharing achievements included making valuable historical datasets available, preparing accessible and easily downloadable datasets, and developing a novel data enclave and/or researcher data platform.
- 14 January 2026
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 35 (2) , 193-197
Open AccessThe Paul Fearn Award for Excellence in Data Sharing in Cancer Control and Population Sciences
The secondary use of data can accelerate innovation and drive discoveries, tool development, and reproducibility. Though data sharing can be challenging, policies and incentives can help facilitate and reward these efforts. To maximize the value of data produced through NIH awards, the NIH recently set forth comprehensive, modern data sharing requirements for all funded research with the 2023 NIH Data Management and Sharing Policy. In light of this new comprehensive policy, the NCI’s Division of Cancer Control and Population Sciences (DCCPS) saw an opportunity to reward exemplary data sharers and add an incentive for future data sharing through the development of an award. In 2024, DCCPS established the “Paul Fearn Award for Excellence in Data Sharing” to promote recognition and celebrate data sharing within the field of population sciences. In its inaugural year, the award was given to researchers from four different projects, each exemplary in the sharing of DCCPS-funded work. Each awardee went above and beyond data sharing requirements to make data reusable for others. Their distinct data sharing achievements included making valuable historical datasets available, preparing accessible and easily downloadable datasets, and developing a novel data enclave and/or researcher data platform.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from The Impact of Improved Treatments on Survival of Adult U.S. Leukemia Patients: 1990–2018
Supplementary Figure 1: Trends in Mortality by Leukemia Subtypes and Race Ethnicity. Total US 1992-2018. Results are shown for mortality trends for CML (panel A), ALL (panel B), and CLL (panel C), 1992-2018. For each panel, we show age-adjusted mortality rates by five mutually exclusive race-ethnicity categories: non-Hispanic White, non-Hispanic Black, non-Hispanic Asian Pacific Islander, non-Hispanic American Indian/Alaskan Natives, and Hispanic.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from The Impact of Improved Treatments on Survival of Adult U.S. Leukemia Patients: 1990–2018
Supplementary Figure 1: Trends in Mortality by Leukemia Subtypes and Race Ethnicity. Total US 1992-2018. Results are shown for mortality trends for CML (panel A), ALL (panel B), and CLL (panel C), 1992-2018. For each panel, we show age-adjusted mortality rates by five mutually exclusive race-ethnicity categories: non-Hispanic White, non-Hispanic Black, non-Hispanic Asian Pacific Islander, non-Hispanic American Indian/Alaskan Natives, and Hispanic.
- 1 November 2025
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 117 (11) , 2417-2418
Stat Bite: Urban and Rural Lung Cancer Mortality Trends in the United States
- 1 November 2025
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 117 (11) , 2417-2418
Stat Bite: Urban and Rural Lung Cancer Mortality Trends in the United States
- 19 August 2025
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 117 (9) , 1960
Stat Bite: Prevalence of cancer in the United States in 2022
- 19 August 2025
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 117 (9) , 1960
Stat Bite: Prevalence of cancer in the United States in 2022